Outcomes	Siblings n = 1728	Haploidentical n = 217
2 yr Overall Survival	59% (95% CI 56–61%)	57% (95% CI 50–65%) NS
2 yr Progression Free Survival	52% (95% CI 50–55%)	48% (95% CI 40–55%) NS
2 yr Relapse	28% (95% CI 25–30%)	24% (95% CI 18–30%) NS
2 yr Non Relapse Mortality	20% (95% CI 18–22%)	28% (95% CI 22–35%) p = 0.012